why choose us

First received: November 25, 2022

Clinical Trial: Synbiotics Interventions for Managing Cirrhosis and Its Complications

Study Status: Completed

Recruit Status: Completed

Condition: Cirrhosis, Liver
Metagonimiasis

Study Type: Interventional


Official Title: Alterations in the Intestinal Microbiome and Metabolic Profile of Patients With Cirrhosis Supplemented With Lactulose, Clostridium Butyricum, and Bifidobacterium Longum Infantis: a Randomized Placebo-

Brief Summary: Background Liver cirrhosis is commonly accompanied by intestinal dysbiosis and metabolic defects. Many clinical trials have shown microbiota-targeting strategies represent promising interventions for managing cirrhosis and its complications. However, the influences of the intestinal metagenomes and metabolic profiles of patients have not been fully elucidated.Methods administered lactulose, Clostridium butyricum, and Bifidobacterium longum infantis as a synbiotic and used shotgun metagenomics and non-targeted…

Read more